PARAMOUNT: Phase III study of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo plus BSC immediately following induction treatment with pem plus cisplatin for advanced nonsquamous non-small cell lung cancer (NSCLC).

L. G. Paz-Ares; F. De Marinis; M. Dediu; M. Thomas; J. Pujol; P. Bidoli; O. Molinier; T. P. Sahoo; E. Laack; M. Reck; J. Corral; S. A. Melemed; W. J. John; N. Chouaki; A. Zimmerman; C. M. Visseren Grul; C. Gridelli

doi:10.1200/jco.2011.29.15_suppl.cra7510

PARAMOUNT: Phase III study of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo plus BSC immediately following induction treatment with pem plus cisplatin for advanced nonsquamous non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.cra7510 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. CRA7510-CRA7510 ◽

Cited By ~ 1

Author(s):

L. G. Paz-Ares ◽

F. De Marinis ◽

M. Dediu ◽

M. Thomas ◽

J. Pujol ◽

...

Keyword(s):

Lung Cancer ◽

Supportive Care ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Best Supportive Care ◽

Small Cell ◽

Phase Iii ◽

Induction Treatment ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text

Radiochemotherapy With Cisplatin (P) And Oral Vinorelbine (NVBo) Followed By Consolidation With Vinorelbine/Cisplatin Or Best Supportive Care (BSC) In Stage III Non Small Cell Lung Cancer (NSCLC): Preliminary Results From A Phase III Study

10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a2528 ◽

2012 ◽

Author(s):

Amanda L.H. Tufman ◽

Rudolf M. Huber ◽

Michael Flentje ◽

Assaad Chemaissani ◽

Stefan Andreas ◽

...

Keyword(s):

Lung Cancer ◽

Supportive Care ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Best Supportive Care ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Oral Vinorelbine ◽

Phase Iii Study

Download Full-text

Maintenance pemetrexed (Pem) plus best supportive care (BSC) versus placebo (Plac) plus BSC: A randomized phase III study in advanced non-small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2009.27.18s.cra8000 ◽

2009 ◽

Vol 27 (18S) ◽

pp. CRA8000-CRA8000 ◽

Cited By ~ 6

Author(s):

C. P. Belani ◽

T. Brodowicz ◽

T. Ciuleanu ◽

J. H. Kim ◽

M. Krzakowski ◽

...

Keyword(s):

Lung Cancer ◽

Supportive Care ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Best Supportive Care ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text

Phase III study of maintenance gemcitabine (G) and best supportive care (BSC) versus BSC, following standard combination therapy with gemcitabine-carboplatin (G-Cb) for patients with advanced non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7506 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7506-7506 ◽

Cited By ~ 49

Author(s):

C. P. Belani ◽

D. M. Waterhouse ◽

H. Ghazal ◽

S. S. Ramalingam ◽

R. Bordoni ◽

...

Keyword(s):

Lung Cancer ◽

Combination Therapy ◽

Supportive Care ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Best Supportive Care ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text

Evaluation of Changes in Renal Function in a Phase III Study of Maintenance (Mtc) Pemetrexed (Pem) Plus Best Supportive Care (Bsc) Versus Placebo (Plb) Plus Bsc After Induction Treatment (Tx) with Pem Plus Cisplatin for Advanced Nonsquamous Non-Small Cell Lung Cancer (Paramount)

Annals of Oncology ◽

10.1093/annonc/mdu349.36 ◽

2014 ◽

Vol 25 ◽

pp. iv441 ◽

Cited By ~ 2

Author(s):

G. Middleton ◽

C. Gridelli ◽

F. De Marinis ◽

J. Pujol ◽

M. Reck ◽

...

Keyword(s):

Lung Cancer ◽

Renal Function ◽

Supportive Care ◽

Small Cell Lung Cancer ◽

Best Supportive Care ◽

Small Cell ◽

Phase Iii ◽

Induction Treatment ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text

A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/s0169-5002(00)00094-5 ◽

2000 ◽

Vol 27 (3) ◽

pp. 145-157 ◽

Cited By ~ 231

Author(s):

Kazimierz Roszkowski ◽

Anna Pluzanska ◽

Maciej Krzakowski ◽

Alexander Peter Smith ◽

Eugeni Saigi ◽

...

Keyword(s):

Lung Cancer ◽

Supportive Care ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Best Supportive Care ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text

Taxotere® (TXT) versus best supportive care (BSC) in chemonaive patients with unresectable non-small cell lung cancer (NSCLC): Final results of the phase iii study

European Journal of Cancer ◽

10.1016/s0959-8049(99)81396-3 ◽

1999 ◽

Vol 35 ◽

pp. S246 ◽

Cited By ~ 8

Author(s):

K. Roszkowski

Keyword(s):

Lung Cancer ◽

Supportive Care ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Best Supportive Care ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text

24 Phase III study of gemcitabine (Gemzar®) versus best supportive care (BSC) in advanced non-small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/s0169-5002(97)89303-8 ◽

1997 ◽

Vol 18 ◽

pp. 9 ◽

Cited By ~ 17

Author(s):

H. Anderson ◽

B. Cottier ◽

M. Nicolson ◽

R. Milroy ◽

T. Maughan ◽

...

Keyword(s):

Lung Cancer ◽

Supportive Care ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Best Supportive Care ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text

Evaluation of changes in renal function in PARAMOUNT: a phase III study of maintenance pemetrexed plus best supportive care versus placebo plus best supportive care after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer

Current Medical Research and Opinion ◽

10.1080/03007995.2018.1439462 ◽

2018 ◽

Vol 34 (5) ◽

pp. 865-871 ◽

Cited By ~ 2

Author(s):

Gary Middleton ◽

Cesare Gridelli ◽

Filippo De Marinis ◽

Jean-Louis Pujol ◽

Martin Reck ◽

...

Keyword(s):

Lung Cancer ◽

Renal Function ◽

Supportive Care ◽

Small Cell Lung Cancer ◽

Best Supportive Care ◽

Small Cell ◽

Phase Iii ◽

Induction Treatment ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text

PARAMOUNT: Descriptive Subgroup Analyses of Final Overall Survival for the Phase III Study of Maintenance Pemetrexed versus Placebo Following Induction Treatment with Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1097/jto.0000000000000076 ◽

2014 ◽

Vol 9 (2) ◽

pp. 205-213 ◽

Cited By ~ 5

Author(s):

Martin Reck ◽

Luis G. Paz-Ares ◽

Filippo de Marinis ◽

Olivier Molinier ◽

Tarini Prasad Sahoo ◽

...

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Induction Treatment ◽

Small Cell Lung ◽

Subgroup Analyses ◽

Phase Iii Study

Download Full-text

Long-Term and Low-Grade Safety Results of a Phase III Study (PARAMOUNT): Maintenance Pemetrexed Plus Best Supportive Care Versus Placebo Plus Best Supportive Care Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer

Clinical Lung Cancer ◽

10.1016/j.cllc.2014.06.007 ◽

2014 ◽

Vol 15 (6) ◽

pp. 418-425 ◽

Cited By ~ 23

Author(s):

Jean-Louis Pujol ◽

Luis Paz-Ares ◽

Filippo de Marinis ◽

Mircea Dediu ◽

Michael Thomas ◽

...

Keyword(s):

Lung Cancer ◽

Supportive Care ◽

Best Supportive Care ◽

Small Cell ◽

Phase Iii ◽

Induction Treatment ◽

Low Grade ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text